Abstract
The results of several clinical trials in metastatic colorectal cancer presented in 2014 will influence clinical practice. These findings include definitive data from phase III trials comparing bevacizumab and cetuximab-based therapy in the first-line, studies elucidating the value of maintenance therapy after induction treatment, and data on new agents in this disease.
Original language | English (US) |
---|---|
Pages (from-to) | 73-74 |
Number of pages | 2 |
Journal | Nature Reviews Clinical Oncology |
Volume | 12 |
Issue number | 2 |
DOIs | |
State | Published - Feb 17 2015 |
ASJC Scopus subject areas
- Oncology